Related Articles
New enzyme‑targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer
Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer
Non-surgical care for locally advanced breast cancer: Radiologically assessed therapeutic outcome of a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II) with systemic chemotherapy
Actual practice of Kochi oxydol radiation therapy for unresectable carcinomas by intra‑tumoral administration of hydrogen peroxide as a radiosensitizer
Therapeutic response to a novel enzyme‑targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane